Loading...
•
Mar 31
Semler Scientific Q1 2025 Earnings Report
Semler Scientific reported a significant net loss driven by DOJ-related expenses and unrealized bitcoin losses.
Key Takeaways
Semler Scientific faced a challenging Q1 2025, posting a $64.7 million net loss largely due to a $29.8 million DOJ contingent liability and a $41.8 million unrealized loss on bitcoin holdings. Despite lower revenue year-over-year, the company expanded its bitcoin treasury and launched a public-facing bitcoin metrics dashboard.
Net loss reached $64.7 million, primarily due to DOJ settlement liability and bitcoin fair value losses.
Revenue dropped 44% year-over-year to $8.8 million.
Company added 894 bitcoins during the quarter, bringing total holdings to 3,192 BTC as of March 31.
A new bitcoin metrics dashboard was launched for real-time disclosure of digital asset KPIs.
Semler Scientific
Semler Scientific
Forward Guidance
Semler Scientific is optimistic about future growth from cardiovascular products while continuing to execute its bitcoin accumulation strategy, but faces uncertainty from regulatory and financial pressures.
Positive Outlook
- Launched a bitcoin dashboard for real-time transparency.
- Continued accumulation of bitcoin using operational and financing sources.
- Anticipated revenue growth from FDA-cleared cardiovascular products.
- Secured new $500M ATM equity program.
- Convertible note issuance provides additional liquidity.
Challenges Ahead
- High legal liabilities related to DOJ settlement.
- Significant unrealized losses due to bitcoin volatility.
- Revenue dropped 44% YoY, indicating core business pressure.
- Operating cash flow was negative for the quarter.
- Sales tax audit and legal costs added financial strain.